KHRNF News and Press, Khiron Life Sciences Corp From 11/16/22

Khiron Life Sciences ( OTCQX:KHRNF ) said it began sales in Switzerland and expanded its product offerings in Germany and the U.K. Khiron entered the Swiss medical cannabis market with the first sales of two of its new flower products, KHIRON Gelato 19/1 and...

Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom Canada NewsWire Through its newly acquired EU-GMP distribution hub in Germany , Khiron expands its product portfolio and geographic reach within Europe&#...

Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference Canada NewsWire TORONTO , Sept. 13, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfur...

Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California Canada NewsWire New products to be distributed through Khiron's new wholly-owned subsidiary Pharmadrug Production GmbH Khiron intro...

Khiron Life Sciences Corp. (KHRNF) Q2 2022 Earnings Conference Call August 29, 2022 10:00 AM ET Company Participants Paola Ricardo - Investor Relations Alvaro Torres - CEO and Co-Founder Helen Bellewood - Interim CFO Franziska Katterbach - President-Europe ...

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) posted results that showed healthy margins despite revenues slightly slumping over the quarter amid the company’s international bid. The pharmaceutical cannabis company announced today its financial results for the ...

Khiron Life Sciences press release ( OTCQX:KHRNF ): Q2 GAAP EPS of -C$0.01. Revenue of C$4.47M (+59.6% Y/Y). Adjusted EBITDA -C$2.3M For further details see: Khiron Life Sciences GAAP EPS of -C$0.01, revenue of C$4.47M

Khiron Life Sciences Reports Second Quarter 2022 Financial Results Canada NewsWire Reports revenues of $9.1 million in the first half of 2022, up 62% year-over-year, reflecting continued medical cannabis momentum in target markets Recorded its lowest ever Adjus...

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022 Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)( Frankfurt : A2JMXC), the global leader in medical ...

Khiron Life Sciences (OTCQX: KHRNF) is a leading vertically integrated international medical cannabis corporation with core operations in Latin America and Europe. Leveraging medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, ph...